NanoVibronix, Inc. announced that independent life expectancy testing performed by Carmel Labs in Israel confirm that its PainShield met all tested functionalities.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7617 USD | -0.92% | +2.93% | -33.77% |
1st Jan change | Capi. | |
---|---|---|
-33.77% | 2.14M | |
-4.91% | 183B | |
+0.46% | 108B | |
-3.62% | 67.51B | |
+3.26% | 50.67B | |
+9.11% | 44.7B | |
+3.26% | 40.95B | |
+6.39% | 26.8B | |
+3.83% | 26.71B | |
+14.60% | 24.62B |
- Stock Market
- Equities
- NAOV Stock
- News NanoVibronix, Inc.
- NanoVibronix, Inc. Receives Positive Final Results of Independent Lifecycle Testing of PainShield Prompted by Centers for Medicare and Medicaid Services